Diagnosis and treatment of shock types. Recommendations of the interdisciplinary working group of the DIVI - Part V: Septic schock;Zur diagnostik und therapie der schockformen empfehlungen der interdisziplinären arbeitsgruppe schock der DIVI - Teil V: Septischer schock

Anasthesiologie und Intensivmedizin

Volumn 46, Issue 7-8, 2005, Pages 285-295

  Bauer, M ^a   Gansslen A ^a   Gartner R ^a   Hoflich C ^a   Koppen J A ^a   Raum, M R ^a   Schareck, W ^a   Wiersbitzky, M ^a   Unterberg, A ^a   Yekebas E ^a   Adams, Hans Anton ^a,b   Baumann, G ^a   Cascorbi, I ^a   Ebener, C ^a   Emmel, M ^a   Geiger, S ^a   Janssens, U ^a   Klima, U ^a   Klippe, H J ^a   Knoefel, W T ^a   Marx, G ^a   Muller Werdan U ^a   Pape, H C ^a   Piek, J ^a   Prange, H ^a   Roesner, D ^a   Roth, B ^a   Schurholz T ^a   Standl, T ^a   Teske, W ^a   Vogt, P M ^a   Werner, G S ^a   Windolf, J ^a   Zander, R ^a   Zerkowski, H R ^a   more..

^a Medizinische Hochschule Hannover ^*

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ADRENALIN; AMRINONE; ANTITHROMBIN III; ARGIPRESSIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; GLUCOCORTICOID; MILRINONE; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ABDOMINAL COMPARTMENT SYNDROME; BREATHING; CLINICAL FEATURE; HUMAN; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 23844549978     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Adams HA, Baumann G, Gänsslen A, Janssens U, Knoefel W, Koch T, Marx G, Müller-Werdan U, Pape HC, Prange H, Roesner D, Standl T, Teske W, Werner G, Zander R und die IAG Schock (2001) Die Definitionen der Schockformen. Intensivmed 38:541-553
2. Alderson P, Bunn F, Lefebvre C, Li WP, Li L, Roberts I, Schierhout G (2002) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev: CD001208
3. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871
4. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709
5. Bisonni RS, Holtgrave DR, Lawler F, Marley DS (1991) Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials. J Fam Pract 32: 387-390
6. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26: 645-650
7. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655
8. Bone RC, Fisher CJ jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317: 653-658
9. Boussat S, Jacques T, Levy B, Laurent E, Gache A, Capellier G, Neidhardt A (2002) Intravascular volume monitoring and extravascular lung water in septic patients with pulmonary edema. Intensive Care Med 28: 712-718
10. Cain SM, Curtis SE (1991) Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Crit Care Med 19: 1552-1560
11. Choi PT, Yip G, Quinonez LG, Cook DJ (1999) Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27: 200-210
12. Creteur J, De Backer D, Vincent JL (1999) Does gastric tonometry monitor splanchnic perfusion? Crit Care Med 27: 2480-2484
13. Davies AO (1984) Rapid desensitization and uncoupling of human beta-adrenergic receptors in an in vitro model of lactic acidosis. J Clin Endocrinol Metab 59: 398-405
14. Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31: 946-955
15. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmermann JL, Vincent JL, Levy MM, for the Surviving Sepsis Campaign Management Guidelines Committee (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873
16. Desjars P, Pinaud M, Bugnon D, Tasseau F, Potel G, Touze MD, Hesselvik JF, Brodin B (1989) Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 17: 426-429
17. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD, Hesselvik JF, Brodin B (1987) A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 15: 134-137
18. Donati A, Conti G, Loggi S, Munch C, Coltrinari R, Pelaia P, Pietropaoli P, Preiser J-P (2002) Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med 30: 2271-2277
19. Dünser M, Wenzel V, Mayr AJ, Hasibeder WR (2002) Arginin-Vasopressin im vasodilatatorischen Schock. Ein neuer Therapieansatz? Anaesthesist 51: 650-659
20. Duke GJ, Briedis JH, Weaver RA (1994) Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 22: 1919-1925
21. Evgenov OV, Bjertnaes LJ (2003) Administration of methylene blue in human septic shock: renaissenance of an old drug? Crit Care Med 31: 1601-1602.
22. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayr M, Calatzis A, Schobersberger W (2002) The effect of combined administration of colloids and lactated Ringer's solution on the coagulation system: An in vitro study using thrombelastograph coagualation analysis (ROTEG). Anesth Analg 94: 1280-1287
23. Gallagher J, Fisher C, Sherman B, Munger M, Meyers B, Ellison T, Fischkoff S, Barchuk WT, Teoh L, Velagapudi R (2001) A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-alpha antibody afelimomab in patients with sepsis syndrome. Intensive Care Med 2: 1169-1178
24. Giraud GD, MacCannell KL (1984) Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther 230: 214-220
25. Gracias VH, Braslow B, Johnson J, Pryor J, Gupta R, Reilly P, Schwab CW (2002) Abdominal compartment syndrome in the open abdomen. Arch Surgery 137: 1298-1300
26. Gutierrez G, Clark C, Brown SD, Price K, Ortiz L, Nelson C (1994) Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 150: 324-329
27. Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J, Dubin A, Schiavi E, Jorge M, Pusajo J, Klein F, Roman ES, Dorfman B, Shottlender (1992) Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 339: 195-199
28. Hannemann L, Reinhart K, Grenzer O, Meier-Hellmann A, Bredle DL (1995) Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 23: 1962-1970
29. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164: 396-402
30. Hesselvik JF, Brodin B (1989) Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 17: 179-180
31. Hobson KG, Young KM, Ciraulo A, Palmieri TL, Greenhalgh DG (2002) Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma 53: 1129-1134
32. Joly LM, Monchi M, Cariou A, Chiche JD, Bellenfant F, Brunet F, Dhainaut JF (1999) Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med 160: 1983-1986
33. Kern H, Schröder T, Kaulfuss M, Martin M, Kox WJ, Spies CD (2001) Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 29: 1519-1525
34. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S (2001) Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 29: 1159-1163
35. Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbjørnsson B, Nedashkovsky EV, Bjertnaes LJ (2001) Infusion of methylene blue in human spetic shock: A pilot, randomized, controlled study. Crit Care Med 29: 1860-1867
36. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31: 2646-265
37. Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) APACHE II: A severity of disease classification system. Crit Care Med 13: 818-829
38. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115: 462-474
39. Kruse JA (1993) Lactic Acidosis. In: Carlson RW, Geheb MA (Eds) Principles & practice of medical intensive care. WB Saunders Company, Philadelphia: 1231-1244
40. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 23: 282-287
41. Levy B, Bollaert PE, Lucchelli JP, Sadoune LO, Nace L, Larcan A (1997) Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med 25: 1649-1654
42. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, for the International Sepsis Defintions Conference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepis Definitions Conference. Crit Care Med 31: 1250-1256
43. Lundberg JS, Perl TM, Wiblin T, Costigan MD, Dawson J, Nettleman MD, Wenzel RP (1998) Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 26: 1020-1024
44. Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C (2002) An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 347: 993-1000
45. Margarson MP, Soni NC (2002) Effects of albumin supplementation on microvascular permeabilitiy in septic patients. J Appl Physiol 92: 2139-2145
46. Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272: 1354-1357
47. Marik PE, Zaloga GP (2001) Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 29: 2264-2270
48. Marshall JC (2000) Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med 26 Suppl 1: S75-83
49. Martin C, Eon B, Saux P, Aknin P, Gouin F (1990) Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 18: 282-285
50. Marx G (2003) Fluid therapy in sepsis with capillary leakage. Eur J Anaesthesiol 20: 429-442
51. Marx G, Cope T, McCrossan L, Swaraj S, Cowan C, Mostafa SM, Wenstone R, Leuwer M (2004) Assessing fluid responsiveness by stroke volume variation in mechanically ventilated patients with severe sepsis. Eur J Anaesthesiol 21: 132-138
52. Max M (2003) Aktiviertes Protein C. Bei Sepsis obligat? Anaesthesist 52: [Suppl 1] S 32-S 39
53. Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochemical Pharmacology 45: 367-374
54. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC (1995) Increasing splanchnic blood flow in the critically ill. Chest 108: 1648-1654
55. McGillivray-Anderson KM, Faber JE (1990) Effect of acidosis on contraction of micro vascular smooth muscle by alpha 1- and alpha 2-adrenoceptors. Implications for neural and metabolic regulation. Circ Res 66: 1643-1657
56. McNelis J, Marini CP, Jurkiewicz A, Fields S, Caplin D, Stein D, Ritter G, Nathan I, Simms HH (2002) Predictive factors associated with the development of abdominal compartment syndrome in the surgical intensive care unit. Arch Surg 137: 133-136
57. Meier-Hellmann A (2003) Standards in der Diagnostik und Therapie der Sepsis. Anasthesiol Intensivmed Notfallmed Schmerzther 38: 107-133
58. Meier-Hellmann A, Bredle DL, Specht M, Hannemann L, Reinhart K (1999) Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Crit Care Med 27: 2166-2171
59. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L (1997) Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25: 399-404
60. Morales DL, Gregg D, Helman DN, Williams MR, Naka Y, Landry DW, Oz MC (2000) Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 69: 102-106
61. Neviere R, Mathieu D, Chagnon JL, Lebleu N, Wattel F (1996) The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 154: 1684-1688
62. O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine- resistant septic shock. Lancet 359: 1209-1210
63. Panacek EA, Marshall J, Fischkoff S, Barchuk W, Teoh L (2000) Neutralization of TNF by a monoclonal antibody improves survival and reduces organ dysfunction in human sepsis: results of the MONARCS trial. Chest 118 (Suppl.): S88
64. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576-582
65. Perel A, Berkenstedt H, Segal E (1999) Continuous arterial thermodilution cardiac output and derived variables. In: Vincent J (Ed) Yearbook of intensive care and emergency medicine. Springer, Berlin: 459-467
66. Peters G (2001) Mikrobilogisches Monitoring. In: Van Aken H, Reinhart K, Zimpfer M (Hrsg) Intensivmedizin. Thieme, Stuttgart: 375-379
67. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273: 117-123
68. Reinhart K, Sakka SG, Meier-Hellmann A (2000) Haemodynamic management of a patient with septic shock. Eur J Anaesthesiol 17: 6-17
69. Reynolds HN, Haupt MT, Thill-Baharozian MC, Carlson RW (1988) Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit. JAMA 260: 3446-3450
70. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377
71. Sakka SG, Bredle DL, Reinhart K, Meier-Hellmann A (1999) Comparison between intrathoracic blood volume and cardiac filling pressures in the early phase of hemodynamic instability of patients with sepsis or septic shock. J Crit Care 14: 78-83
72. Sakka SG, Reinhart K, Meier-Hellmann A (2002) Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 122: 1715-1720
73. Sakka SG, Reinhart K, Wegscheider K, Meier-Hellmann A (2000) Is the placement of a pulmonary artery catheter still justified solely for the measurement of cardiac output? J Cardiothorac Vasc Anesth 14: 119-124
74. Sakka SG, Rühl CC, Pfeiffer UJ, Beale R, McLuckie A, Reinhardt K, Meier-Hellmann A (2000) Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med 26: 180-187
75. Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316: 961-964
76. Schneider F, Lutun Ph, Hasselmann M, Stoclet JC, Tempé JD (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18: 309-311
77. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomized study. Lancet 357: 911-916
78. Spiegel T von, Wietasch G, Bursch J, Hoeft A (1996) Cardiac output determination with transpulmonary thermodilution. An alternative to pulmonary catheterization? Anaesthesist 45: 1045-1050
79. Temmesfeld-Wollbruck B, Szalay A, Mayer K, Olschewski H, Seeger W, Grimminger F (1998) Abnormalities of gastric mucosal oxygenation in septic shock: partial responsiveness to dopexamine. Am J Respir Crit Care Med 157: 1586-1592
80. The International Sepsis Forum (2001) Guidelines for the management of severe sepsis and septic shock. Intensive Care Med 27 Suppl 1: S1-134
81. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317: 659-665
82. Van den Berghe G, Wouters P, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31: 359-366
83. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359-1367
84. Varga C, Pavo I, Lamarque D, Szepes Z, Kiss J, Karacsony G, Laszlo FA, Laszlo F (1998) Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. Eur J Pharmacol 352: 257-261
85. Velanovich V (1989) Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 105: 65-71
86. Vincent LJ, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G (2002) Reducing mortality in sepsis: new directions. Critical Care 6 (Suppl 3): S1-S18
87. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM; KyberSept Trial Study Group (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286: 1869-1878
88. Wilkes MM, Navickis RJ (2001) Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 135: 149-164